MBX-102/JNJ39659100, a Novel Peroxisome Proliferator Activated Receptor-γ Ligand with Weak Transactivation Activity Retains Full Anti-Diabetic Properties in the Absence of Side Effects
Author(s) -
Francine M. Gregoire,
Fang Zhang,
Holly J. Clarke,
Thomas A. Gustafson,
Dorothy D. Sears,
Svetlana Favelyukis,
James M. Lenhard,
Dennis Rentzeperis,
L. Edward Clemens,
Yi Mu,
Brian E. Lavan
Publication year - 2009
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jcem.94.6.9995
Subject(s) - transactivation , peroxisome proliferator activated receptor , peroxisome , chemistry , receptor , ligand (biochemistry) , medicine , pharmacology , biophysics , microbiology and biotechnology , biochemistry , biology , transcription factor , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom